Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis
Clinical trial NCT02986139 · COMPLETED
Trial details
- NCT number
- NCT02986139
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2017-09-08
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.